Batrafen, created in 1954 (Germany), from 2757 sister brands and 17477 competing brands. The Batrafen brand is owned by SANOFI, a company listed in Paris. The International Securities Identification Number (ISIN) of SANOFI is FR0000120578. Batrafen is part of the Drug Manufacturers activity sector.